NPC002
Laufzeit: 01.01.2017 - 31.12.2018
imported
Kurzfassung
Arimoclomol prospective double-blind, randomised, placebo-controlled study in patients diagnosed with Niemann-Pick disease type C
Laufzeit: 01.01.2017 - 31.12.2018
Arimoclomol prospective double-blind, randomised, placebo-controlled study in patients diagnosed with Niemann-Pick disease type C